Düsseldorf (ots) - Dr. Bernd Metzner (48) is to become Chief Financial Officer of Gerresheimer AG, taking up office at the latest on July 1, 2019. Dr. Bernd Metzner has been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. "In Dr. Bernd Metzner, we have gained a highly experienced Chief ...One document
Reduction of single-use plastics needs to tie in with circular economy actions and consumption realities in Europe
Berlin (ots) - The European Parliament approved yesterday its report on the draft Directive on Marine Pollution and Single-use Plastics. "European Bioplastics fully supports the transition from a linear to a circular economy. Bioplastics enable more sustainable solutions for a range of products", says François de ...
Declaring war on plastic to save our oceans: the world's major climate financiers EIB, KfW and AFD launch a EUR 2 billion initiative
Frankfurt am Main (ots) - Ahead of the IMF/World Bank Group meetings, KfW Group on behalf of the German Federal Government, the European Investment Bank (EIB) and the Agence Française de Developpement (AFD) launched the Clean Oceans Initiative to support the development and implementation of sustainable projects ...
Düsseldorf (ots) - - Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m - Adjusted EBITDA at constant exchange rates - excluding Sensile Medical and negative effects relating to the exemption from electricity network charges - increased by ...One document
Düsseldorf (ots) - Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new career challenges. The Supervisory Board of Gerresheimer AG approved this wish at its meeting yesterday. Andreas Schütte has served on the ...One document
Micro pump for Parkinson's treatment from Gerresheimer subsidiary Sensile Medical receives European CE declaration of conformity
Duesseldorf/Olten (ots) - A wearable micro pump from Sensile Medical has received EU certification for the European market. A European pharma company has obtained a CE declaration of conformity for the pump, which is specially designed for the treatment of Parkinson's ...One document
Düsseldorf (ots) - - With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers. The purchase price is a ...One document
Düsseldorf (ots) - - Revenues at constant exchange rates EUR 299.2m in first quarter of 2018, as expected, stable relative to prior-year period; organic revenue growth 0.4% - Adjusted EBITDA at constant exchange rates EUR 54.9m, as budgeted below the EUR 59.0m prior-year figure - Development of US dollar against ...One document
Düsseldorf (ots) - On December 22, 2017, the US President signed the US tax reform, also known as the Tax Cuts and Jobs Act. The main changes from Gerresheimer's standpoint concern the reduction of the federal corporate tax rate from previously 35 % to now 21 % effective from January 1, 2018 and the elimination of certain previously available deductions from taxable income. There are also additional ...One document
EU Plastics Strategy misses chance to fully embrace the benefits of bio-based and biodegradable plastics
Berlin (ots) - The European Strategy for Plastics, published on Tuesday by the European Commission, sets clear goals to curb plastic waste, increase resource efficiency, and to create job growth in Europe, but falls short on presenting a comprehensive approach by limiting the focus of the strategy on mechanical recycling. Concrete steps towards reducing the dependency on fossil feedstock by linking the ...
New studies confirm: biodegradable plastics boost organic recycling and improve mechanical recycling
Berlin (ots) - Biodegradable plastics offer innovative solutions to improve recycling quality by facilitating the means for more efficient separate waste collection. This has been confirmed by a new study concerning the effects of biodegradable plastics on plastics recycling streams in Italy, where all single-use carrier bags have to be compostable since 2011. Analysing the quality of recycled plastics from ...
Düsseldorf (ots) - - Revenues in second quarter of 2017 down 2.2% to EUR 339.5m as expected - Adjusted EBITDA margin 22.3%, versus 23.2% in prior-year quarter - Slight increase in Adjusted EBITDA leverage to 2.7 due to dividend payout and bond interest - More specific guidance for the financial year 2017 After a moderate second quarter, Gerresheimer AG expects revenues to recover in the second half of the year. "Revenues decreased slightly in the ...One document
Duesseldorf (ots) - - Revenues down 5.4% in first quarter of 2017 to EUR 302.8m - Adjusted EBITDA margin at 19.8%, as in prior year - EBITDA leverage unchanged at 2.6 - Guidance for financial year 2017 confirmed, with consolidated revenues initially at lower end of range Gerresheimer AG made a moderate start to ...One document
Düsseldorf (ots) - - Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One Equity Partners - Total transaction enterprise value of USD 131m for 100% of the business In line with its strategy of focusing on packaging and device solutions for pharmaceutical customers, ...One document
Duesseldorf (ots) - - Revenues up 4.0% to EUR 370.5m - Adjusted EBITDA rises 17.5% to EUR 84.7m - Adjusted EBITDA margin climbs to 22.8% - Adjusted earnings per share surpass prior-year quarter by 34.5% to reach EUR 1.13 Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, ...One document
Duesseldorf (ots) - - Revenues in financial year 2015 up 6.8% to EUR 1,377.2m - Adjusted EBITDA climbs to EUR 277.9m - Adjusted earnings per share rise 18.0% to EUR 3.41 - Proposed dividend of EUR 0.85 per share (2014: EUR 0.75 per share) - Centor acquisition, sale of glass tubing business and refinancing successfully completed - Approximately 9% revenue ...One document
Duesseldorf (ots) - - Revenues up 6.2% to EUR 344.0m, 3.1% on organic basis - Adjusted EBITDA rises 9.5% to EUR 68.0m - Adjusted net income increases by 28.3% to EUR 29.2m - Adjusted earnings per share climb to EUR 0.85 - Operating cash flow up by EUR 58.6m to EUR 104.5m in Q1-Q3 - Guidance reiterated for financial ...One document
Duesseldorf (ots) - - Revenues up 6.3% to EUR 356.4m (1.9% on an organic basis) - Adjusted EBITDA rises 10.6% to EUR 72.1m - Net income grows by 7.4% to EUR 22.4m - Earnings per share lifted to EUR 0.65 - Guidance confirmed for financial year 2015 - Refinancing successfully completed Gerresheimer AG kept up its ...One document
Duesseldorf (ots) - - Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) - Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) - Net income climbs 22.8% to EUR 12.7m (Q1 2014: EUR 10.3m) - Earnings per share up 20.7% on prior-year quarter, at EUR 0.35 - Guidance confirmed for 2015 - Cross reference: Press release including table is available ...One document
Duesseldorf (ots) - - Revenues up 1.9% (3.7% organically) to EUR 1,290.0m - Adjusted EBITDA totals EUR 258.5m at constant exchange rates - Earnings per share up 6.6% to EUR 2.11 - Proposed dividend of EUR 0.75 per share (prior year: EUR 0.70 per share) - International expansion continues Gerresheimer AG, one of the leading partners to the pharma and ...One document
Berlin (ots) - The results of European Bioplastics' annual market data update, presented today at the 9th European Bioplastics Conference in Brussels, confirm the positive growth trend of the global bioplastics industry. "The market is predicted to grow by more than 400 percent in the mid-term," stated François de Bie, Chairman of European Bioplastics. The ...
Düsseldorf/Dongguan City (People's Republic of China) (ots) - Gerresheimer AG, an internationally leading partner to the pharma and healthcare industry, has opened a new Development Center for medical plastic systems in Dongguan City, China. Now Gerresheimer has three such centers in Wackersdorf (Germany), Peachtree City (United States of America) and now ...One document
Duesseldorf/Buende (ots) - - Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare - Growing importance of drug delivery and dosage devices in Western markets and of pharmaceutical primary packaging business in emerging markets - Mid-term growth potential 2016 to 2018: 4% to 6% ...One document
Duesseldorf (ots) - - Revenues up 2.6% to EUR 335.4m (6.0% at constant exchange rates) - Adjusted EBITDA rises 9.1% to EUR 65.1m (14.1% at constant exchange rates) - Net income grows by 70.3% to EUR 20.8m - EUR 0.61 earnings per share higher than prior-year quarter (Q2 2013: EUR 0.34) - Guidance for financial year ...One document